Advaxis (OTC: ADXS)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-06-13 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.000 | ||||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Advaxis (OTCQX: ADXS) through any online brokerage.
There are no as such competitors for Advaxis.
The latest price target for Advaxis (OTCQX: ADXS) was reported by HC Wainwright & Co. on Tuesday, December 18, 2018. The analyst firm set a price target for 0.00 expecting ADXS to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for Advaxis (OTCQX: ADXS) is $0.0649 last updated May 19, 2022, 7:57 PM UTC.
There are no upcoming dividends for Advaxis.
Advaxis’s Q2 earnings are confirmed for Monday, June 13, 2022.
There is no upcoming split for Advaxis.
Advaxis is in the Health Care sector and Biotechnology industry. They are listed on the OTCQX.